VIB

Working on #ALS, #Parkinson's, or #Alzheimer’s? Then why aren’t you registered yet for #NHND25?
Don’t miss the 25 Sept deadline, and the opportunity to join the #neurodegenerative crowd of the year. Virtual tickets available.
👉: vibbio.tech/48k46g2

#VIBConf #Neuroinflammation #neuronaldisease

Understanding #neurodegenerative diseases is critical, which is precisely why #NHND25 matters and why you should be in the room.
Today is the last chance to save your spot with Early Bird rates and have one less thing to remember later: vibbio.tech/46d4ydn
#VIBConf #Neuroinflammation

@nature.com

#Microbes aren’t just cute under a microscope, they’re global problem-solvers. See it in action: sustainable farming, food tech, microbial cell factories, and more at #Microbes25. Got research pushing these boundaries? Today’s the last day, submit your abstract: vibbio.tech/4n5VSMV
#VIBConf

What’s next in neurodegenerative disease research? Be part of the conversation at #NHND25, connect with experts & peers to explore & discuss the intricate world of #neurodegeneration. Don’t miss the early bird deadline, secure your discounted registration by 11 Sept: vibbio.tech/4mg9ll6
#VIBConf

📆Mark your calendar! We're excited to announce the 3rd ed. of Type 2 Immunity in #Homeostasis and Disease. Join us in Ghent for a 2-day conference on 9 & 10 March 2026. #Type2Immunity26 will focus on evolving insights into type 2 immunity pathways beyond its classical boundaries: vibbio.tech/3UwmTNk

Calling all #Microbes25 enthusiasts, it’s time to show off your finest science. Do not leave it trapped in your lab. Submit your abstract by September 4 & have a chance to win the Nature Microbiology Poster Prize: vibbio.tech/3UQkrkN.

@natmicrobiol.nature.com

#MicrobialBiotech #MicrobialEcology

The #NHND25 early bird deadline is almost upon us. Don’t miss out on new models to study #neurodegeneration, #neuroinflammation in action, genetic twists, fresh takes on therapeutics, and much more.

Save your budget and grab your spot by Sept 11: vibbio.tech/4fcWygQ

#neuronaldisease #VIBConf

𝐈t'𝐬 𝐬𝐜𝐢𝐞𝐧𝐜𝐞. 𝐈𝐭'𝐬 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥.

We’re sharing real stories from our scientists, because the person behind the science is crucial: What drives them? Where did it all begin? What keeps them going?

🎥 Coming soon.

#ScienceStories #ComingSoon #BehindTheScience

𝐒𝐨𝐦𝐞𝐭𝐡𝐢𝐧𝐠 𝐧𝐞𝐰 𝐢𝐬 𝐜𝐨𝐦𝐢𝐧𝐠. A series of raw, unfiltered conversations that highlights the voices of researchers, their challenges, breakthroughs, and what drives them every day.

Authentic, personal and powerful.

📅 Launch: April 29

#DrivenByScience

𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝘁𝗮𝗸𝗲 𝘆𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗳𝘂𝗿𝘁𝗵𝗲𝗿? Join VIB – where top science meets global talent!

PhD, postdoc or PI – grow your career in a vibrant, cutting-edge research environment in Belgium.
👉 vib.be/en/careers

#LifeAtVIB #ResearchExcellence #MoveToBelgium

Research from the VIB-UGent Center for Medical Biotechnology reveals a promising way to overcome drug resistance in multiple myeloma by blocking a key protein — potentially improving treatment outcomes for patients ▶️ vibbio.tech/43W40cE
#MultipleMyeloma #CancerResearch #DrugResistance

🤯 Blocking an enzyme can reprogram immune cells to improve cancer treatments? Check out our latest research by Massimiliano Mazzone, Samantha Pretto, and colleagues
@vib-ccb.bsky.social! @erc.europa.eu europa.eu
@fwovlaanderen.bsky.social
👉 Read our complete story: vibbio.tech/421Syum

🧠 Exploring 300 million years of brain evolution through the lens of enhancer codes, by @niklaskemp.bsky.social @steinaerts.bsky.social, Nikolai Hecker @science.org @vibai.bsky.social @cbdresearch.bsky.social @fwovlaanderen.bsky.social @chanzuckerberg.bsky.social @erc.europa.eu 👉 vibbio.tech/3QDWhbn

Excited to introduce Sebastiaan 'Seppe' De Schepper, our new group leader at the VIB-UAntwerp Center for Molecular!
👉 Read why we're thrilled to have him on the VIB team: vibbio.tech/3CBoTyo
Welcome aboard, Sebastiaan! 🙌

𝗗𝗲𝗰𝗼𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴🧬
As part of our Revolutionizing Next-Generation Sequencing conference, we spoke with Wouter De Coster and Bram Van den Bergh @vibmicrobes.bsky.social 👉 Read here vibbio.tech/4jEqqnQ
Join us at #RNGS25:
📅 19-21 March 2025
🔗 vibbio.tech/4gABdNv
⏰ Early Bird: 5 Feb

🔬 New research by @michielslab.bsky.social @liselotdewachter.bsky.social @vibmicrobes.bsky.social in @naturecomms.bsky.social shows how protein 'clumps' drive bacteria into a state of dormancy, with implications for antibiotic resistance. ➡️ Read here vibbio.tech/40Qxc2M
🙌 FWO Vlaanderen - KU Leuven

⌛The 6th edition of #RNGS25 is approaching quickly. Don't miss out and register before the Early bird deadline of February 5: vibbio.tech/3Wtt8CQ

🤝 Expand your network with the leaders in the field of #sequencing and get inspired by the latest discoveries presented in engaging presentations.

🎉 Thrilled to share the launch of our VIB Training & Conferences Program – offering transformative training and conference experiences to empower scientists and research support staff.

Check it out 👇

Conference: Diversity in science

Join us at the Diversity in Science Conference

📆 February 7, 2025
📍 Gasthuisberg Campus, Leuven
✍️ Registration: vibbio.tech/3CbYzuD

Open to everyone passionate about diversity in science - students, researchers, and more!

🙌 Organized by KU Leuven’s Department of Cellular and Molecular Medicine.

🤯 New work by @ginevradoglioni.bsky.social, @fendtlab.bsky.social, and colleagues finds a role for the amino acid in cancer metastasis.
@vib-ccb.bsky.social
(👉 vibbio.tech/40hLskI)

✨🎉 As 2024 comes to a close and we welcome 2025, the entire VIB team would like to extend our warmest wishes. Here’s to another year of progress and possibilities 🎆

👉 Stay informed in 2025 by following our updates on vib.be!

👀 How does the brain process visual information?
New research by @boninlab.bsky.social and colleagues @nerflabs.bsky.social suggests it's more complicated than we thought. ➡️ Read more: vibbio.tech/4fpG17s

👇The video shows how visual information is transmitted in the brain.

Xiao-Zheng Liu, postdoc at @vib-ccb.bsky.social @fendtlab.bsky.social, wins Belgian L’Oréal-UNESCO For Women in Science Award
➡️ Read here: vibbio.tech/3Bhl0OB
🔬 Her work aims to identify metabolic vulnerabilities and prevent metastasis at an early stage.

🎉 Congratulations!

🧠 New insights into the genetic factors that drive Alzheimer’s disease
👉 Read here: vibbio.tech/4izHlYc
🔬 Study led by Prof. Kristel Sleegers of VIB-UAntwerp Center for Molecular Neurology @uantwerpen.bsky.social @alzassociation.bsky.social

💉 A new 'triplet lipid nanoparticle' can stimulate the immune system to attack tumors
🙌 Developed by Damya Laoui (VIB-VUB Center for Inflammation Research), etherna, and colleagues @vlaio.bsky.social
➡️ Read more: vibbio.tech/4gqrMjE

𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗼𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: an intro to Flamingo Therapeutics🦩

Flamingo Therapeutics, a VIB spin-off company, is spearheading the development of antisense technology in oncology. ➡️ Read their full story: vibbio.tech/49oVbbL

💡 Stay tuned for our next episode!

🎗️ A team of researchers from 𝗩𝗜𝗕-𝗞𝗨 𝗟𝗲𝘂𝘃𝗲𝗻 𝗖𝗲𝗻𝘁𝗲𝗿 𝗳𝗼𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 @nkinl.bsky.social 𝗢𝗻𝗰𝗼𝗱𝗲 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 has found that the menstrual cycle phase may influence the effectiveness of chemotherapy in breast cancer
➡️ Read more: vibbio.tech/3OEtaU5

🌱 Plants use little pores (stomata) to respond to environmental changes. Work by @ivedesmet1978.bsky.social and colleagues (@psb-vib.bsky.social #UGent) reveals the mechanism regulating the stomata response to heat & drought, especially relevant in the context of climate change: vibbio.tech/49e7Y0T

𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗼𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: 𝗔 𝗡𝗲𝘄 𝗦𝗲𝗿𝗶𝗲𝘀 𝗯𝘆 𝗩𝗜𝗕
At VIB, we're turning groundbreaking research into real-world solutions. ➡️ Our spin-offs are at the forefront of this journey
📣 Read their stories in our quarterly series
📅 Kicking off next week with Flamingo Therapeutics
👉 Stay tuned investors.vib.be